February 16-17, 2013


Doubletree by Hilton Orlando at Seaworld
10100 International Drive
Orlando, FL 32821
Telephone: (407) 352-1100

About the Meeting

Meeting Objectives:

  • Review the clinical trial and translational science data with VEGF-targeted and mTOR-targeted therapy for patients with advanced RCC.
  • Define clinical and translational questions that need to be addressed in clinical trials to improve the initial therapy of advanced RCC patients.
  • Develop two clinical trial designs that would address the developed questions.

Go to Go to Go to